Prevalence of age-related macular degeneration in the United States.
暂无分享,去创建一个
[1] A. Hofman,et al. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. , 2003, Archives of ophthalmology.
[2] B. Rovner,et al. Activity loss and depression in age-related macular degeneration. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[3] Beatriz Munoz,et al. Causes of blindness and visual impairment in a population-based sample of U.S. Hispanics. , 2002, Ophthalmology.
[4] R M Kaplan,et al. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. , 2001, Ophthalmology.
[5] N. Bressler,et al. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. , 1999, Archives of ophthalmology.
[6] Jie-Jin Wang,et al. Age‐specific prevalence and causes of bilateral and unilateral visual impairment in older Australians: the Blue Mountains Eye Study , 2000, Clinical & experimental ophthalmology.
[7] J. J. Wang,et al. The prevalence of age-related maculopathy: the visual impairment project. , 2000, Ophthalmology.
[8] G. Rubin,et al. Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study. , 2000, Archives of ophthalmology.
[9] H. Taylor,et al. Age-specific causes of bilateral visual impairment. , 2000, Archives of ophthalmology.
[10] S C Jensen,et al. Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III. , 1999, Ophthalmology.
[11] D. Friedman,et al. Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey. , 1999, Ophthalmology.
[12] A Hofman,et al. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. , 1998, Archives of ophthalmology.
[13] K Bandeen-Roche,et al. Function and visual impairment in a population-based study of older adults. The SEE project. Salisbury Eye Evaluation. , 1997, Investigative ophthalmology & visual science.
[14] J. J. Wang,et al. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. , 1995, Ophthalmology.
[15] M. C. Leske,et al. Features of Age-Related Macular Degeneration in a Black Population , 1995 .
[16] P T de Jong,et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration , 1995 .
[17] Johannes R. Vingerling,et al. The prevalence of age-related maculopathy in the Rotterdam Study. , 1995, Ophthalmology.
[18] R. Klein,et al. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. , 1995, Investigative ophthalmology & visual science.
[19] R. Klein,et al. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. , 1992, Ophthalmology.
[20] J Katz,et al. Racial differences in the cause-specific prevalence of blindness in east Baltimore. , 1991, The New England journal of medicine.